AGBL LABS™ offers transformative innovations in preconception screening empowered by GenePeeks, a U.S.-based computational genomics company.
- GenePeeks Preconception Screen identifies parental risk of passing on more than 1,000 serious genetic diseases.
- Virtual Progeny Analytics (VPA) approach combines DNA information from two potential parents to predict the future genome of a child prior to conception.
- Proprietary Variant Gene Dysfunction (VGD) scoring system predicts gene function and associated disease risk for each mutation in the virtual child’s genome.
- A comprehensive genetic report for the healthcare provider and the patient.
Saliva sample collection kits for analysis are available through AGBL LABS™ at firstname.lastname@example.org